Essayer OR - Gratuit

Saving Lives with BSL-4 Labs

Bio Spectrum

|

February 2026

Starting a new era of India's health security, a biosafety level 4 (BSL-4) lab is being built at the cost of Rs 362 crore at Gujarat Biotechnology Research Centre in Gandhinagar. Although this will be India's second high-level lab after the National Institute of Virology in Pune (established in 2012), this is the first lab being built by a state government, with an area of 11,000 square metres. Back in 2024, the Defence Research and Development Organisation (DRDO) took a significant step in enhancing India's chemical-biological defence capabilities with the inauguration of a BSL-4 laboratory at the Defence Research and Development Establishment (DRDE) in Gwalior.

- Dr Manbeena Chawla

Saving Lives with BSL-4 Labs

India has been lagging behind for many years due to the cutting-edge research being done in the world, but the establishment of such BSL-4 bio-containment facilities in the country can provide new opportunities to the youth working in the biotechnology sector and help India emerge as a global leader in years to come.

According to reports, with 3,000 square metres of lab space, the Wuhan Institute of Virology in China is one the largest BSL-4 lab in the world, later overtaken by the National Bio and Agro-Defense Facility at Kansas State University in the US which boasts over 50,000 square metres of lab space including BSL-3 and BSL-4 facilities.

The global distribution of BSL-4 laboratories has evolved significantly over the past few decades, reflecting the growing recognition of the need for high-containment facilities in various regions. While historically concentrated in North America and Europe, there has been a notable increase in BSL-4 labs across Asia, Africa, and Australia in recent years.

PLUS D'HISTOIRES DE Bio Spectrum

Bio Spectrum

Park Medi World buys KP Institute of Medical Sciences for Rs 245 Cr

Park Medi World Limited, North India's second largest chain of hospitals, has agreed to acquire KP Institute of Medical Sciences (KPIMS), in an all-cash transaction amounting to Rs 245 crore.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Biofabri and Bharat Biotech ink technology transfer agreement to advance global access to MTBVAC

Biofabri, a global human vaccine development company that is part of Spain-based Zendal group, and Bharat Biotech International Limited (BBIL) in Hyderabad, a global leader in vaccine innovation and manufacturing, have announced the signing of a Technology Transfer Agreement.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

PM launches Ayush Mark, setting global quality benchmarks for India's traditional medicine

In a historic and visionary move that marks a defining moment for India's traditional medicine ecosystem, Prime Minister (PM) Narendra Modi has launched the Ayush Mark, establishing a globally aligned quality certification framework for Ayush products and services.

time to read

1 min

February 2026

Bio Spectrum

Novo Nordisk launches world's most prescribed GLP-1 drug Ozempic in India

Novo Nordisk, a global healthcare company, has announced the launch of Ozempic (injectable semaglutide) in India.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Symbiotec Pharmalab files DRHP with SEBI for IPO aggregating upto Rs 2180 Cr

Indore-based Symbiotec Pharmalab, a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across three platforms-organic chemistry, biotechnology and complex injectables, has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI).

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Centre announces special dispensation to deep-tech startups in DSIR accreditation process

Union Minister of State (Independent Charge) for Science and Technology Dr Jitendra Singh has announced a major relaxation in the mandatory three-year survival condition for deep-tech startups to get recognition under the Industrial R&D Promotion Programme of Department of Scientific and Industrial Research (DSIR).

time to read

1 min

February 2026

Bio Spectrum

Kashiv BioSciences secures Rs 648 Cr financing from UBI

Kashiv BioSciences, a biopharmaceutical company, has secured financing of Rs 648 crore from the Union Bank of India.

time to read

1 min

February 2026

Bio Spectrum

S&T Minister inaugurates Biotechnology Research and Innovation Council (BRIC) Secretariat

The Union Minister of (Independent State Charge) for Science and Technology (S&T) Dr Jitendra Singh recently inaugurated the Biotechnology Research and Innovation Council (BRIC) Secretariat by unveiling the inaugural curtain, marking the official opening of a new milestone in India's biotechnology journey.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Senores Pharmaceuticals makes Rs 91 Cr acquisition of Apnar Pharma

Senores Pharmaceuticals has entered into a definitive agreement to acquire 100 per cent equity stake in Apnar Pharma, along with the acquisition of five Abbreviated New Drug Applications (ANDAs), marking a significant milestone in Senores' growth strategy across regulated pharmaceutical markets.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Intas Pharmaceuticals collaborates with IntegriMedical

Ahmedabad-based Intas Pharmaceuticals has entered into an exclusive agreement with IntegriMedical, the technology leader behind India's first NeedleFree Injection System (N-FIS), to introduce this revolutionary technology for use in IVF and gynaecology treatments across India. This marks a significant milestone in IVF and women's health.

time to read

1 min

February 2026

Listen

Translate

Share

-
+

Change font size